Skip to main content
. 2014 May 5;8:431–446. doi: 10.2147/DDDT.S59523

Figure 1.

Figure 1

Dipeptidyl peptidase-4 inhibition prolongs the active state of the gut hormone glucagon-like peptide, leading to enhanced insulin secretion in the presence of elevated plasma glucose.

Abbreviations: DPP-4, dipeptidyl peptidase-4; GIP, gastric inhibitory peptide; GLP-1, glucagon-like peptide.